halofuginone has been researched along with Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cetinel, Ş; Karadeniz Cerit, K; Karakoyun, B; Özkan, N; Tolga Dağli, E; Tuğtepe, H; Yeğen, BÇ; Yüksel, M | 1 |
1 other study(ies) available for halofuginone and Kidney Diseases
| Article | Year |
|---|---|
The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Fibrosis; Glutathione; Kidney Diseases; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Nephrectomy; Oxidative Stress; Peroxidase; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Rats; Rats, Wistar; Reperfusion Injury | 2013 |